Myristoylated ARF6 (2-13)
Myristoylated ARF6 (2-13) blocks MyD88–ARNO–ARF6–signaling axis by deactivating ARF6[1].
Product Specifications
UNSPSC
12352209
Target
Arf Family GTPase; MyD88
Type
Peptides
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/myristoylated-arf6-2-13.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC1=CC=CC=C1)C(NCC(N[C@@H](CC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H](CCC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CNC(CCCCCCCCCCCCC)=O
Molecular Formula
C74H128N16O18
Molecular Weight
1529.90
References & Citations
[1]Chadwick T Davis, et al. ARF6 Inhibition Stabilizes the Vasculature and Enhances Survival during Endotoxic Shock. J Immunol. 2014 Jun 15;192 (12) :6045-52.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog